VICKS Drug Patent Profile
✉ Email this page to a colleague
When do Vicks patents expire, and when can generic versions of Vicks launch?
Vicks is a drug marketed by Warner Chilcott and is included in one NDA.
The generic ingredient in VICKS is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vicks
A generic version of VICKS was approved as diphenhydramine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VICKS?
- What are the global sales for VICKS?
- What is Average Wholesale Price for VICKS?
Summary for VICKS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for VICKS |
| DailyMed Link: | VICKS at DailyMed |
US Patents and Regulatory Information for VICKS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Warner Chilcott | VICKS FORMULA 44 | diphenhydramine hydrochloride | SYRUP;ORAL | 070524-001 | Jan 14, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
